3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Osteosarcoma
29
Dendritic Cell Sarcoma, Interdigitating
25
Lymphoma
20
Burkitt Lymphoma
20
Lymphoma, Large B-Cell, Diffuse
18
Precursor Cell Lymphoblastic Leukemia-Lymphoma
16
Lymphoma, Non-Hodgkin
16
Leukemia
16
Lymphoma, Large-Cell, Immunoblastic
15
Lymphoma, Follicular
14
Sarcoma
13
Recurrence
13
Multiple Myeloma
13
Leukemia, Myeloid, Acute
13
Leukemia, Lymphocytic, Chronic, B-Cell
13
Lymphoma, Mantle-Cell
12
Lymphoma, B-Cell, Marginal Zone
12
Hodgkin Disease
12
Neoplasms, Plasma Cell
11
Myelodysplastic Syndromes
11
Leukemia, Myeloid, Accelerated Phase
11
Myeloproliferative Disorders
10
Leukemia, Myelomonocytic, Chronic
10
Congenital Abnormalities
10
Leukemia, Myelomonocytic, Juvenile
9
Leukemia, Myeloid, Chronic-Phase
9
Blast Crisis
9
Sezary Syndrome
8
Primary Myelofibrosis
8
Mycosis Fungoides
8
Interventions
glucarpidase
2
ripretinib
1
gamma-Glutamyl Hydrolase
1
Zoledronic Acid
1
Methotrexate
1
Leucovorin
1
Carboxypeptidases
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Renal Insufficiency
×
Methotrexate
×
Sarcoma
×
Clear all
NCT00634504
2022-06-06
LVPK
BTG International Inc.
Phase 1
Completed
20 enrolled
9 charts